Product
|
FGF-8, Human
|
Cat#
|
101-19-35B
|
Sequence
|
MQVTVQSSPN FTQHVREQSL VTDQLSRRLI RTYQLYSRTS
GKHVQVLANK RINAMAEDGD PFAKLIVETD TFGSRVRVRG
AETGLYICMN KKGKLIAKSN GKGKDCVFTE IVLENNYTAL
QNAKYEGWYM AFTRKGRPRK GSKTRQHQRE VHFMKRLPRG
HHTTEQSLRF EFLNYPPFTR SLRGSQRTWA PEPR
|
Unit/Weight
|
50 μg
|
Unit Price
|
$152.00
|
Description
|
Fibroblast Growth Factor-8 (FGF-8) is a heparin-binding growth factor of the FGF family. There are 4 known forms of FGF8 produced by alternative splicing: FGF8a, FGF-8b, FGF-8e and FGF-8f. The human and mouse FGF8b are identical of aa sequences. FGF-8 plays an important role in the regulation of embryonic development, cell proliferation, cell differentiation and cell migration. FGF-8 is required for normal brain, eye, ear and limb development during embryogenesis. It is also required for normal development of the gonadotropin- releasing hormone (GnRH) neuronal system.
Recombinant human Fibroblast Growth Factor-8 (rhFGF-8) produced in E. coli is a single non-glycosylated polypeptide chain containing 194 amino acids. A fully biologically active molecule, rhFGF-8 has a molecular mass of 22.5kDa analyzed by reducing SDS-PAGE and is obtained by proprietary chromatographic techniques at Pepmic.
|
Molecular Weight
|
22.5kDa, observed by reducing SDS-PAGE.
|
Purity
|
> 95% by SDS-PAGE and HPLC analyses.
|
Storage
|
Lyophilized recombinant human Fibroblast Growth Factor-8 (rhFGF-8) remains stable up to 6 months at -80°C from date of receipt. Upon reconstitution, rhFGF-8 should be stable up to 2 weeks at 4°C or up to 3 months at -20°C.
|
|